Novartis AG (NVS) is considering a deal for radiopharmaceutical company Advanced Accelerator Applications SA (AAAP) as the giant Swiss drugmaker seeks acquisitions to boost growth, according to people familiar with the matter.
Update(s):
October 30, 2017: Novartis has agreed to buy French-based Advanced Accelerator Applications (AAAP) for $3.9 billion (£2.95 billion).